Markets:

Overview

News

Currencies

International

Treasuries

Enlivex Therapeutics Ltd. - Ordinary Shares (NQ:ENLV)

0.8217 -0.0243 (-2.87%)

Streaming Delayed Price Updated: 11:58 AM EST, Dec 17, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Enlivex Therapeutics Ltd. - Ordinary Shares

< Previous 1 2 3 4 5 6 Next >

Enlivex to Present at the 4th Macrophage-Directed Therapies Summit

October 03, 2022

From Enlivex Therapeutics Ltd

Via GlobeNewswire

Roger Pomerantz And Shai Novik Say They're Racing To Change The Odds Of Cancer Treatments ↗

July 14, 2022

Cancer research has come a long way in the past few decades, pioneering treatments like chemotherapy and radiation treatments that have become essential weapons in the fight against this deadly and...

Via Benzinga

Changing The Landscape Of Cancer Therapy With Macrophages? How One Israeli Company Reports It's Looking To Do Just That ↗

July 05, 2022

One of the chief challenges cancer researchers face today is finding a way to outsmart the disease’s defense mechanisms.

Via Benzinga

Reprogramming Imbalanced Macrophage Populations May Play A Key Role In Resolving Cancer And Various Inflammatory Disorders ↗

June 23, 2022

Shai Novik, Executive Chairman of the Board at Enlivex Therapeutics, Ltd. (NASDAQ: ENLV), was a guest speaker at Benzinga’s All Access on June 17th, 2022.

Via Benzinga

Monkeypox Could Reportedly Trigger An Uptick In Sepsis Cases But This Israeli Biotech Company Says It May Have Found A Treatment ↗

June 17, 2022

As the mysterious monkeypox outbreak has many scientists on heightened alert, the rare virus could pose an additional threat to a global population still reeling from the COVID-19 pandemic.

Via Benzinga

Will Another Enlivex Innovation Break The Glass Ceiling For Solid Tumor Treatments? ↗

June 14, 2022

Cell therapy — the use of stem cells and various engineered immune cells to target difficult-to-treat diseases like cancer and autoimmune conditions — has arguably been one of the big breakthroughs in...

Via Benzinga

Should Biotech Be On The Critical List? ↗

May 11, 2022

The risk-off market has played havoc with the biotechs where the fundamentals have not changed as much as the valuation.

Via Talk Markets

51 Biggest Movers From Yesterday ↗

April 07, 2022

Gainers Advent Technologies Holdings, Inc. (NASDAQ: ADN) shares climbed 79.7% to close at $3.63 on Wednesday. Advent Technologies and Hyundai Motor Company entered into...

Via Benzinga

World Markets News For Thursday ↗

February 17, 2022

Ericsson stock lost another 5.27% today in US markets.

Via Talk Markets

Inflation inflating ↗

February 10, 2022

The Fed will be raising interest rates soon and this will chop the appeal of investments in more vulnerable yield plays.

Via Talk Markets

Weakened Tech Stocks ↗

February 03, 2022

There was a 0.5% rise in UK interest rates, twice what had been anticipated and moreover early, because of inflation risks.

Via Talk Markets

Drug Troubles ↗

January 28, 2022

The drug sector has both good news and bad.

Via Talk Markets

Stocks That Hit 52-Week Lows On Thursday ↗

February 03, 2022

On Thursday, 105 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows And Highs: Meta Platforms (NASDAQ:FB) was the biggest company on...

Via Benzinga

Market Trend: Erratic And Unreliable ↗

December 29, 2021

Given the risks of covid variants and hefty price rises, the stock market should not be as buoyant as it is.

Via Talk Markets

Tuesday Markets Coverage ↗

November 23, 2021

GE was up on hopes for cheaper oil. But most stocks were down on oil price hike fears.

Via Talk Markets

Wednesday Market Overview ↗

November 10, 2021

Inflation came in at 6.2% in October which boosted gold and of course the new hedge, bitcoin

Via Talk Markets

Election Day ↗

November 02, 2021

Teva rose a whopping 8.34% today.

Via Talk Markets

A Bit Of A Recovery ↗

September 29, 2021

While Germany remains without a government, Japan has a new prime minister who will lead his party in the election this week.

Via Talk Markets

China's Rescue Of Evergrand ↗

September 23, 2021

The number of jobless last week was higher than the forecast, at 351,000 vs 320,000. The recovery is lagging.

Via Talk Markets

Vaccine Victory ↗

August 24, 2021

Monday the US stock market moved into further robust mode fueled by official FDA approval of the Pfizer and BioNTech COVID-19 vaccines. Will the momentum last through to Thursday when the Fed's Jackson...

Via Talk Markets

Topics Economy

54 Biggest Movers From Yesterday ↗

September 02, 2021

Gainers Focus Universal Inc. (NASDAQ: FCUV) shares climbed 278% to close at $19.28 on Wednesday. The stock started trading on Nasdaq Capital Market yesterday. Sequential Brands...

Via Benzinga

Now That The FDA Approved Pfizer-BioNTech, Is This It For Vaccine Stocks? ↗

August 23, 2021

If there's one thing to take away from any conversation about biotech stocks, it's that any company with their hat in the ring is likely making a version of something they hope to be better than the...

Via Talk Markets

55 Biggest Movers From Yesterday ↗

September 01, 2021

Gainers Unico American Corporation (NASDAQ: UNAM) shares gained 59% to close at $4.15 on Tuesday. Elys Game Technology, Corp. (NASDAQ: ELYS) rose 43% to close at $6.62 after it...

Via Benzinga

Mid-Afternoon Market Update: Dow Turns Positive; Sesen Bio Shares Plummet ↗

August 16, 2021

Toward the end of trading Monday, the Dow traded up 0.03% to 35,526.99 while the NASDAQ fell 0.34% to 14,771.91. The S&P also rose, gaining 0.02% to 4,468.88. The U.S. has the...

Via Benzinga

Topics Stocks

60 Biggest Movers From Yesterday ↗

August 17, 2021

Gainers NanoVibronix, Inc. (NASDAQ: NAOV) shares jumped 33.7% to close at $3.37 on Monday after the company announced plan to expand product portfolio with introduction of...

Via Benzinga

Mid-Day Market Update: Crude Oil Down Over 2%; Travere Therapeutics Shares Jump ↗

August 16, 2021

Midway through trading Monday, the Dow traded down 0.36% to 35,388.46 while the NASDAQ fell 1.24% to 14,639.36. The S&P also fell, dropping 0.54% to 4,443.76. The U.S. has the...

Via Benzinga

Topics Stocks

38 Stocks Moving In Monday's Mid-Day Session ↗

August 16, 2021

Gainers NanoVibronix, Inc. (NASDAQ: NAOV) shares climbed 34.5% to $3.3900 after the company announced plan to expand product portfolio with introduction of Painshield relief for...

Via Benzinga

Enlivex Therapeutics Stock Jumps On Initiation Of Another Mid-Stage COVID-19 Trial ↗

August 16, 2021

The Israeli Ministry of Health has signed off Enlivex Therapeutics Ltd's (NASDAQ: ENLV) Phase 2b trial evaluating Allocetra in severe and critical COVID-19...

Via Benzinga

24 Stocks Moving in Monday's Pre-Market Session ↗

August 16, 2021

Gainers Enlivex Therapeutics Ltd. (NASDAQ: ENLV) shares rose 26.6% to $12.87 in pre-market trading after the company disclosed that after reviewing its earlier-reported Phase II...

Via Benzinga

Friday the Thirteenth ↗

August 13, 2021

The stock week in points eastward was mixed. The USA markets face a bear correction.

Via Talk Markets

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Enlivex Therapeutics Ltd. - Ordinary Shares (NQ:ENLV)

All News about Enlivex Therapeutics Ltd. - Ordinary Shares

Starting at $3.75/week.

Subscribe Today